Global Healthcare POS Terminals Market to Reach $10.6 Billion at a CAGR of 16.3%

The “Healthcare POS Terminals Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 To 2029” report has been added to ResearchAndMarkets.com’s offering.

The growing need to track patient information and restructure payment practices across the healthcare industry are identified as the major factors driving the uptake of POS terminals in the healthcare industry. In addition, growing healthcare infrastructure in form of hospitals, clinic, and diagnostic labs coupled with the changing payment landscape is also expected to shape market demand during the forecast period.

The market experts across the globe are voicing their support for card-based payments at healthcare facilities as it would not only be convenient (cash-less) for patients, but also enable providers to streamline their payment practice and benefit from new auditing capabilities.

All these factors are collectively expected to favor market demand during the forecast period. The global healthcare POS terminals market is expected to register strong growth, growing at a CAGR of 16.3% during the forecast period 2021 – 2029 and exceeding US$ 10.6 Bn by 2029.

Report Scope
This report analyzes the global healthcare POS terminals market in terms of product component, application, and geography. On the basis of product type, the market is segmented into mobile and wireless POS terminals, and fixed POS terminals.

Similarly, on the basis of application, the market for healthcare POS Terminals is further classified into restaurants, lodging establishments, and resorts among others. The geographical distribution of the global healthcare POS terminals market considered in this study encompasses regional markets such as North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Key Topics Covered:

1. Preface

2. Executive Summary

3. Global Healthcare POS Terminals Market Analysis

4. Global Healthcare POS Terminals Market Revenue, By Product , 2019 – 2029 (US$ Bn)

5. Global Healthcare POS Terminals Market Revenue, By Component , 2019 – 2029 (US$ Bn)

6. Global Healthcare POS Terminals Market Revenue, By Application, 2019 – 2029 (US$ Bn)

7. North America Healthcare POS Terminals Market Analysis, 2019 – 2029 (US$ Bn)

8. Europe Healthcare POS Terminals Market Analysis, 2019 – 2029 (US$ Bn)

9. Asia Pacific Healthcare POS Terminals Market Analysis, 2019 – 2029 (US$ Bn)

10. Rest of World Healthcare POS Terminals Market Analysis, 2019 – 2029 (US$ Bn)

11. Company Profiles

 Companies Mentioned

  • Ingenico S.A.
  • NCR Corporation
  • MICROS Systems Inc.
  • PAX Technology Limited
  • VeriFone Systems Inc.
  • Cisco Systems Inc.
  • Hewlett-Packard Company
  • Toshiba Corporation
  • Panasonic Corporation
  • Samsung Electronics Co. Ltd.

For more information about this report visit here.

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.